News

Profound Medical Corp. Unveils Key Financial Insights Soon

Profound Medical Corp. Unveils Key Financial Insights Soon

Profound Medical Set to Release Third Quarter Financial Results

Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a leading medical device company specializing in innovative, incision-free therapies for treating disease, is gearing up to deliver its financial results for the third quarter of 2024. Investors and stakeholders will be eagerly awaiting the insights that come with these results, expected to be released following the market's close.

Conference Call Details

The management team at Profound will hold a conference call at 4:30 p.m. ET to discuss the financial performance from the last quarter and share updates on the company's strategic direction.

Why Attend the Conference Call?

This event will not only cover the latest financial data but also shed light on ongoing and upcoming projects that could shape the company's future. Stakeholders will have an opportunity to engage with Profound’s leadership and gain valuable insights into their innovative approaches and market strategies.

About Profound Medical Corp.

As a commercial-stage medical device company, Profound is committed to bringing advanced therapies to patients without the need for surgeries. The flagship product, TULSA-PRO®, represents a significant breakthrough in prostate disease treatment. This technology combines real-time MRI imaging and robotically-controlled ultrasound for precise tissue ablation. TULSA-PRO® allows for minimal disruption while effectively treating conditions such as prostate cancer and benign prostatic hyperplasia (BPH).

The TULSA procedure is noteworthy for its unique approach. It delivers heat to the targeted tissue without requiring incisions or extensive recovery periods. This is particularly beneficial for patients who may be anxious about traditional surgical options. As a result, TULSA-PRO® is carving a niche as a go-to treatment method that meets the needs of varying patient profiles and conditions.

Innovative Therapeutics on the Horizon

In addition to TULSA-PRO®, Profound is also advancing Sonalleve®, an exceptional technology designed for treating uterine fibroids and alleviating pain from bone metastases. Recently sanctioned in multiple jurisdictions, Sonalleve® represents a growing sector within the company's portfolio as they explore further applications of the technology.

With its existing approvals and clinical evidence supporting its efficacy, Sonalleve® is also setting its sights on additional markets where non-invasive ablation techniques could revolutionize treatment options for various forms of cancer.

Looking Ahead: Profound’s Growth Strategy

As Profound Medical Corp. prepares for its pivotal financial call, there is significant intrigue about the upcoming developments and how they align within the company's overarching growth strategy. The focus remains on establishing a stronger presence in the non-invasive treatment market and expanding their portfolio of innovative medical technologies.

By continuously enhancing their product offerings, Profound is well-positioned to take advantage of a growing demand for less invasive treatment methods, catering to a diverse patient population.

Contact Information

For more information about Profound Medical's upcoming conference call and developments, please reach out to:

Stephen Kilmer
Investor Relations
skilmer@profoundmedical.com
T: 647.872.4849

Frequently Asked Questions

What is the main focus of Profound Medical Corp.?

Profound Medical Corp. specializes in developing incision-free therapies for ablation of diseased tissue, particularly for prostate-related conditions.

When will Profound Medical announce its financial results?

The financial results for the third quarter of 2024 will be released after market close on November 7, 2024.

What are the key products offered by Profound Medical?

The key products include TULSA-PRO® for prostate treatments and Sonalleve® for uterine fibroid treatments and pain management.

How can investors participate in the conference call?

Investors can join the conference call by registering through the provided link and participating in the discussion.

What approvals does TULSA-PRO® have?

TULSA-PRO® is CE marked, approved by Health Canada, and has received 510(k) clearance from the U.S. FDA.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
Machine Grabs Prime Dallas Property Amid Apartment Boom

Updated Category News Views 4

Dallas' Hot Market and Machine's Bold Move Well, well, looks like Machine Investment Group's been busy flexing its real estate muscles, bagging a 490-unit gem in North Dallas—your typical, no-frills off-market grab. We’re talking 75 West, nestled in a juicy infill spot, and it’s catching eyes like gold dust in a pan. You don't need me to tell you North Dallas ain't...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 5

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 7

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 6

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 4

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 5

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading

Top 5 Most Recently Viewed Articles

Kelly Advances Pediatrics with Children's Therapy Center Buyout

Updated Category News Views 324

Kelly Expands Pediatric Therapy Reach Through Strategic Acquisition Kelly has recently made a significant move in the therapeutic services sector by acquiring the Children's Therapy Center (CTC). This strategic acquisition marks an essential growth opportunity for Kelly, especially as it pertains to pediatric therapy services. With increasing demands for specialized...

Continue Reading
Insights into Rathbones Group's Recent Stake in Warehouse REIT

Updated Category News Views 154

Key Information on Rathbones Group Plc's Investment In a recent public disclosure, Rathbones Group Plc revealed their significant interests in Warehouse REIT Plc, a company known for its strategic holdings in the warehouse sector. This disclosure is crucial for investors keen on understanding market movements and the implications of major shareholdings. Who is Rathbones...

Continue Reading
Exploring the Surge of Pharmaceutical Contract Sales Market

Updated Category News Views 191

Pharmaceutical Contract Sales Organization Market Overview The pharmaceutical contract sales organization market is set to grow from US$ 8.21 billion in 2022 to US$ 15.82 billion by 2030, boasting a compound annual growth rate (CAGR) of 8.6%. This growth stems from a notable increase in pharmaceutical companies globally seeking specialized sales support and innovative...

Continue Reading
Generational Group Facilitates Clareblend, Inc. Sale Success

Updated Category News Views 74

Generational Group Facilitates Clareblend, Inc. Sale Success Generational Group, a prominent mergers and acquisitions advisory firm dedicated to privately held businesses, proudly announces a significant achievement in the sale of its client, Clareblend, Inc., to the esteemed Silhouet-Tone. This successful acquisition marks a vital step for Clareblend in its journey...

Continue Reading
Dietary Guidelines Highlight Eggs as Nutrient-Dense Superfood

Updated Category News Views 203

Emphasizing the Importance of Protein in Diets The new dietary guidelines stress the necessity of incorporating protein in meals across all age groups, especially emphasizing the nutritional benefits of eggs. As adults and children alike pursue healthier eating habits, eggs have emerged as a paramount source of high-quality protein, offering essential nutrients necessary...

Continue Reading